Make more informed decisions through our In Vitro Contract Research Services
We offer standard and bespoke in vitro studies as a service to screen your novel therapeutic candidates, investigate mechanisms of action and fast-track clinical trial design. Our services are ideal for drug developers who need quick access to organ-on-a-chip (OOC) technology without the need to invest in equipment.
Partner with us to access over a decade of OOC expertise, the most human-relevant in vitro models available, our dedicated team of creative problem solvers, and a proven track record for delivering clinically translatable results.
Your dedicated contact will work with you to design and conduct studies that get results quickly and cost-effectively compared to animal studies. All studies are performed using PhysioMimix® technology to generate human-relevant data that improves your chances of clinical success.
Explore our services
NAFLD / NASH Services
Overcome the limitations of murine models through our complementary service to understand the human efficacy of novel anti-NASH therapeutics. Gain mechanistic insights from a range of disease markers (hepatic steatosis, inflammation, fibrosis) and target pathways.
Drug-induced liver injury Services
Our DILI Services offer a reliable tool for evaluating drug safety in a human-relevant system. We can evaluate multiple endpoints to establish a complete assessment of acute or chronic DILI risk using a wide range of clinically relevant endpoints to determine causality and mechanism of toxicity.
Take a step beyond what’s currently possible to gain deeper insights into the ADME properties of a wide variety of drug modalities. Identify and correlate human-specific metabolites with cell health or more accurately predict bioavailability versus animals to select candidates with desirable profiles.